<p>前威斯康星州州長和美國衞生與公共服務部部長為透皮藥物輸送技術的先鋒帶來了豐富的醫療領導經驗</p>
<p>, /PRNewswire/ -- Vector Science &amp; Therapeutics 今日宣佈，前威斯康星州州長和美國衞生與公共服務部部長湯米·湯普森已加入公司，擔任董事會主席。</p>
<p>繼續閲讀</p>
<p><img src="https://imageproxy.pbkrs.com/https://www.prnewswire.com/news-releases/null?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.prnewswire.com/news-releases/null"/></p>
<p>湯米·湯普森</p>
<p>湯普森的任命為 Vector 帶來了卓越的醫療政策專業知識和領導經驗，幫助公司推進其使命，即為醫生、外科醫生和臨牀醫生提供精準干預措施，以應對精確性至關重要且系統性風險不可接受的情況。公司的開發工作集中在疼痛管理、再生醫學、骨科和癌症領域。湯普森的傑出職業生涯包括擔任威斯康星州最長任期的州長（1987-2001）以及在喬治·W·布什總統任內領導美國衞生與公共服務部（2001-2005），期間他監督了醫療保險現代化和重大醫療保健倡議。</p>
<p>在擔任衞生與公共服務部部長期間，湯普森倡導醫療創新，監督實施醫療保險處方藥福利，並領導國家醫療基礎設施的現代化工作。作為威斯康星州州長，他因開創福利改革和促進經濟發展而聞名，特別是在醫療保健和生物技術領域。</p>
<p>湯普森表示：“Vector Science &amp; Therapeutics 正是我們應對現代醫療挑戰所需的創新思維。Vector 的透皮藥物輸送平台將在靶向治療輸送方面帶來重大進展，有潛力提高治療效果，同時最小化系統性副作用。隨着我們的人口老齡化並越來越依賴多種藥物治療各種疾病，將生物機械和治療干預措施輸送到目標解剖部位變得越來越重要。我很高興能與整個 Vector 團隊合作，推動這些突破性技術的發展。”</p>
<p>在他的職業生涯中，湯普森一直是醫療創新的堅定倡導者，並在眾多醫療相關的董事會和諮詢委員會中任職。他在複雜的監管環境中導航的經驗以及對公共和私營部門醫療動態的理解，將對 Vector 繼續開發和商業化其治療平台至關重要。</p>
<p>Vector Science &amp; Therapeutics 首席執行官比爾·傑克遜表示：“我們很榮幸歡迎湯米·湯普森擔任我們的董事會主席。他在醫療政策方面的無與倫比的經驗，加上他對威斯康星州創新生態系統的深刻理解，使他成為引導 Vector 戰略方向的理想領導者，因為我們致力於將突破性的生物機械和透皮輸送療法帶給臨牀醫生和患者。”</p>
<p><strong>關於 Vector Science &amp; Therapeutics</strong></p>
<p>Vector Science &amp; Therapeutics 成立於 2024 年，位於威斯康星州梅奎恩，開發主動透皮和局部藥物輸送平台，以為臨牀醫生提供精準干預措施，以應對精確性至關重要且系統性風險不可接受的情況。Vector Science &amp; Therapeutics 在多倫多證券交易所創業板上市，股票代碼為 PAIN。有關更多信息，請訪問 https://vectorscience.co/.</p>
<p>來源：Vector Sciences &amp; Therapeutics</p>
<p><img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjYwNDMwJk5ld3NJdGVtSWQ9TEE0NzU0MiZUcmFuc21pc3Npb25fSWQ9MjAyNjA0MzAwODEyUFJfTkVXU19VU1BSX19fX19MQTQ3NTQy?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjYwNDMwJk5ld3NJdGVtSWQ9TEE0NzU0MiZUcmFuc21pc3Npb25fSWQ9MjAyNjA0MzAwODEyUFJfTkVXU19VU1BSX19fX19MQTQ3NTQy"/></p>

VTVT

RTSL

生物科技 ETF - VanEck Vectors

動態生物技術與基因組 ETF - Invesco

標普生物技術 ETF - SPDR

納斯達克生物科技指數 ETF - iShares Nasdaq

2 倍做多納斯達克生物技術 ETF - ProShares

醫藥突破 ETF - ALPS

標普生物技術 3 倍做多 - Direxion

紐交所高增長板生物技術指數 ETF - First Trust

<p>Vector Science & Therapeutics 任命前威斯康星州州長和美國衞生與公共服務部部長湯米·湯普森（Tommy Thompson）為董事會主席。湯普森為公司帶來了豐富的醫療保健領導和政策專業知識，該公司專注於經皮藥物輸送技術。他的經驗包括監督重大醫療保健倡議和倡導醫療保健創新。首席執行官比爾·傑克遜（Bill Jackson）對湯普森能夠引導公司戰略方向以開發突破性療法表示信心</p>

<p>Former Wisconsin Governor and U.S. Secretary of Health and Human Services Brings Extensive Healthcare Leadership to Pioneer of Transdermal Drug Delivery Technology</p>
<div class="lb-trans"><p>前威斯康星州州長和美國衞生與公共服務部部長為透皮藥物輸送技術的先鋒帶來了豐富的醫療領導經驗</p>
</div><p>, /PRNewswire/ -- Vector Science &amp; Therapeutics today announced that Tommy Thompson, former Governor of Wisconsin and U.S. Secretary of Health and Human Services, has joined the company as Chairman of the Board.</p>
<div class="lb-trans"><p>, /PRNewswire/ -- Vector Science &amp; Therapeutics 今日宣佈，前威斯康星州州長和美國衞生與公共服務部部長湯米·湯普森已加入公司，擔任董事會主席。</p>
</div><p>Continue Reading</p>
<div class="lb-trans"><p>繼續閲讀</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.prnewswire.com/news-releases/null" alt="" original-src="https://www.prnewswire.com/news-releases/null"/></p>
<p>Tommy Thompson</p>
<div class="lb-trans"><p>湯米·湯普森</p>
</div><p>Thompson's appointment brings exceptional healthcare policy expertise and leadership experience to Vector as the company advances its mission to equip physicians, surgeons, and clinicians with site-directed interventions where precision matters and systemic risk is unacceptable. The company's developmental work is focused in pain management, regenerative medicine, orthopedics, and cancer. Thompson's distinguished career includes serving as Wisconsin's longest-serving governor (1987-2001) and leading the U.S. Department of Health and Human Services under President George W. Bush (2001-2005), where he oversaw Medicare modernization and major healthcare initiatives.</p>
<div class="lb-trans"><p>湯普森的任命為 Vector 帶來了卓越的醫療政策專業知識和領導經驗，幫助公司推進其使命，即為醫生、外科醫生和臨牀醫生提供精準干預措施，以應對精確性至關重要且系統性風險不可接受的情況。公司的開發工作集中在疼痛管理、再生醫學、骨科和癌症領域。湯普森的傑出職業生涯包括擔任威斯康星州最長任期的州長（1987-2001）以及在喬治·W·布什總統任內領導美國衞生與公共服務部（2001-2005），期間他監督了醫療保險現代化和重大醫療保健倡議。</p>
</div><p>During his tenure as HHS Secretary, Thompson championed healthcare innovation, oversaw the implementation of the Medicare Prescription Drug Benefit, and led efforts to modernize the nation's healthcare infrastructure. As Wisconsin Governor, he was known for pioneering welfare reform and promoting economic development, particularly in the healthcare and biotechnology sectors.</p>
<div class="lb-trans"><p>在擔任衞生與公共服務部部長期間，湯普森倡導醫療創新，監督實施醫療保險處方藥福利，並領導國家醫療基礎設施的現代化工作。作為威斯康星州州長，他因開創福利改革和促進經濟發展而聞名，特別是在醫療保健和生物技術領域。</p>
</div><p>&#34;Vector Science &amp; Therapeutics represents exactly the kind of innovative thinking we need to address the challenges facing modern healthcare,&#34; said Thompson. &#34;Vector's transdermal drug delivery platforms will deliver significant advances in targeted therapy delivery, offering the potential to improve treatment efficacy while minimizing systemic side effects. Delivering biomechanical and therapeutic interventions into targeted anatomy is becoming increasingly important as our population ages and becomes increasingly dependent on poly pharmacy for a range of conditions. I am excited to work with the entire Vector team to help advance these breakthrough technologies.&#34;</p>
<div class="lb-trans"><p>湯普森表示：“Vector Science &amp; Therapeutics 正是我們應對現代醫療挑戰所需的創新思維。Vector 的透皮藥物輸送平台將在靶向治療輸送方面帶來重大進展，有潛力提高治療效果，同時最小化系統性副作用。隨着我們的人口老齡化並越來越依賴多種藥物治療各種疾病，將生物機械和治療干預措施輸送到目標解剖部位變得越來越重要。我很高興能與整個 Vector 團隊合作，推動這些突破性技術的發展。”</p>
</div><p>Throughout his career, Thompson has been a strong advocate for healthcare innovation and has served on numerous healthcare-related boards and advisory committees. His experience navigating complex regulatory environments and understanding of both public and private sector healthcare dynamics will be invaluable as Vector continues to develop and commercialize its therapeutic platforms.</p>
<div class="lb-trans"><p>在他的職業生涯中，湯普森一直是醫療創新的堅定倡導者，並在眾多醫療相關的董事會和諮詢委員會中任職。他在複雜的監管環境中導航的經驗以及對公共和私營部門醫療動態的理解，將對 Vector 繼續開發和商業化其治療平台至關重要。</p>
</div><p>&#34;We are honored to welcome Tommy Thompson as Chairman of our Board,&#34; said Bill Jackson, Chief Executive Officer of Vector Science &amp; Therapeutics. &#34;His unparalleled experience in healthcare policy, combined with his deep understanding of Wisconsin's innovation ecosystem, makes him the ideal leader to guide Vector's strategic direction as we work to bring breakthrough biomechanical and transdermally delivered therapies to clinicians and patients.&#34;</p>
<div class="lb-trans"><p>Vector Science &amp; Therapeutics 首席執行官比爾·傑克遜表示：“我們很榮幸歡迎湯米·湯普森擔任我們的董事會主席。他在醫療政策方面的無與倫比的經驗，加上他對威斯康星州創新生態系統的深刻理解，使他成為引導 Vector 戰略方向的理想領導者，因為我們致力於將突破性的生物機械和透皮輸送療法帶給臨牀醫生和患者。”</p>
</div><p><strong>About Vector Science &amp; Therapeutics</strong></p>
<div class="lb-trans"><p><strong>關於 Vector Science &amp; Therapeutics</strong></p>
</div><p>Founded in 2024 and located in Mequon, Wisconsin, Vector Science &amp; Therapeutics develops active transdermal and localized drug delivery platforms to equip clinicians with site-directed interventions where precision matters and systemic risk is unacceptable. Vector Science &amp; Therapeutics is publicly traded on the TSX Venture Exchange under the ticker symbol PAIN. For more information, visit https://vectorscience.co/.</p>
<div class="lb-trans"><p>Vector Science &amp; Therapeutics 成立於 2024 年，位於威斯康星州梅奎恩，開發主動透皮和局部藥物輸送平台，以為臨牀醫生提供精準干預措施，以應對精確性至關重要且系統性風險不可接受的情況。Vector Science &amp; Therapeutics 在多倫多證券交易所創業板上市，股票代碼為 PAIN。有關更多信息，請訪問 https://vectorscience.co/.</p>
</div><p>SOURCE Vector Sciences &amp; Therapeutics</p>
<div class="lb-trans"><p>來源：Vector Sciences &amp; Therapeutics</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjYwNDMwJk5ld3NJdGVtSWQ9TEE0NzU0MiZUcmFuc21pc3Npb25fSWQ9MjAyNjA0MzAwODEyUFJfTkVXU19VU1BSX19fX19MQTQ3NTQy" alt="" original-src="https://rt.prnewswire.com/rt.gif?NewsItemId=LA47542&amp;Transmission_Id=202604300812PR_NEWS_USPR_____LA47542&amp;DateId=20260430"/></p>

08:12 ETVector Science & Therapeutics Announces Tommy Thompson as Chairman of the Board

prnewswire

vTv Therap

Rapid Therapeutic Science Laboratories, Inc.

Vector Science & Therapeutics 宣佈 Tommy Thompson 擔任董事會主席